Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:44 AM
Study NCT ID:
NCT01083160
Status:
TERMINATED
Last Update Posted:
2012-01-19
First Post:
2010-02-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
Sponsor:
Abbott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-19
First Submit QC Date:
None
Study First Post Date:
2010-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-11-23
Results First Submit QC Date:
None
Results First Post Date:
2012-01-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-17
Last Update Post Date:
2012-01-19
Last Update Post Date Type:
ESTIMATED